Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Therapeutic Effects of Probiotics in Patients with Atopic Dermatitis

  • Yim, Jun-Hee (Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Duk-Han (Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Ku, Ja-Kyung (Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kang, Yoon-Sung (Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Mi-Yeon (Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Hyung-Ok (Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Chung, Myung-Jun (Research Institute of Cell Engineering, Cellbiotech, Co. Ltd.) ;
  • Park, Young-Min (Department of Dermatology, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Published : 2006.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Recent studies have suggested that oral bacteriotherapy with probiotics might be useful for preventing and managing childhood atopic dermatitis (AD). The purpose of this investigation was to evaluate the efficacy and safety of oral treatment with probiotics for adolescent and adult AD patients as well as for childhood AD patients. Sixty-four patients with mild to moderate AD were recruited for treatment with a mixture of four probiotic strains (Lactobacillus rhamnosus, Lactobacillus plantarum, Lactobacillus casei, and Biftdobacterium lactis) twice daily for 8 weeks. The degree of pruritus was determined by a 10-point visual analog scale every other week, and the patients' global assessments of their clinical responses (i.e., better, unchanged, or worse) was done at the end of intervention. The clinical severity of the eczema was evaluated by eczema area and severity index (EASI) score every other week. As laboratory markers, total immunoglobulin E (IgE), eosinophil cationic protein (ECP) in the serum, and cytokine production [interleukin-4 (IL-4), interleukin-10 (IL-10), and $interferon-{\gamma}\;(IFN-{\gamma})$ by the peripheral blood mononuclear cells (PBMCs) were measured at the beginning and at the end of intervention. Of the 64 enrolled AD patients, only 50 patients finally completed the 8-week study. After 8-week treatment with probiotics, the EASI score was significantly improved (p<0.0001), 50% of the patients experienced improvement of their eczema, and significant improvement of the pruritus was also observed (p=0.0002). The effect was more pronounced for the patients with very high IgE levels (>1,000 ku/l) or for the patients with moderate disease severity. There was no significant difference in the therapeutic effects between the childhood AD and adolescent and adult AD patients. There were no significant changes of cytokines, as well as the total IgE and ECP levels, in the patients' serum. Treatment with the mixture of four probiotic strains was generally well tolerated. Our results suggest that the treatment with the mixture of four probiotic strains is beneficial for the management of the adolescent and adult AD patients, as well as for the childhood AD patients.

Keywords

References

  1. Arcari, P., R. Martinelli, and F. Salvatore. 1984. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species. Nucleic Acids Res. 12: 9179-9189 https://doi.org/10.1093/nar/12.23.9179
  2. Eichenfield, L. F., A. W. Lucky, M. Boguniewicz, R. G. B. Langley, R. Cherill, K. Marshall, C. Bush, and M. Graeber. 2002. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J. Am. Acad. Dermatol. 46: 495-504 https://doi.org/10.1067/mjd.2002.122187
  3. Gionchetti, P., F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi, G. Bazzocchi, G. Poggioli, M. Miglioli, and M. Campieri. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119: 305-309 https://doi.org/10.1053/gast.2000.9370
  4. Hanifin, J. M. and G. Rajka. 1980. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. Suppl (Stockh) 92: 44-47
  5. Isolauri E., H. Majamaa, T. Arvola, I. Rantala, E. Virtanen, and H. Arvilommi. 1993. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 105: 1643-1650 https://doi.org/10.1016/0016-5085(93)91059-Q
  6. Isolauri, E., T. Arvolar, Y. Sutas, and S. Salminen. 2000. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30: 1605-1610 https://doi.org/10.1046/j.1365-2222.2000.00943.x
  7. Kalliomaki, M., S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri. 2001. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 357: 1076-1079 https://doi.org/10.1016/S0140-6736(00)04259-8
  8. Kalliomaki, M., S. Salminen, T. Poussa, H. Arvilommi, and E. Isolauri. 2003. Probiotics and prevention of atopic disease: 4-Year follow-up of a randomised placebo-controlled trial. Lancet 361: 1869-1871 https://doi.org/10.1016/S0140-6736(03)13490-3
  9. Kang, S., A. W. Lucky, D. Pariser, I. Lawrence, and J. M. Hanifin. 2001. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J. Am. Acad. Dermatol. 44: S58-S64 https://doi.org/10.1067/mjd.2001.109812
  10. Kuisma, J., S. Mentula, H. Jarvinen, A. Kahri, M. Saxelin, and M. Farkkila. 2003. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment. Pharmaco. Ther. 17: 509-515 https://doi.org/10.1046/j.1365-2036.2003.01465.x
  11. Lewis-Jones, M. S., A. Y. Finlay, and P. J. Dykes. 2001. The infants' dermatitis quality of life index. Br. J. Dermatol. 144: 104-110 https://doi.org/10.1046/j.1365-2133.2001.03960.x
  12. Majamaa, H. and E. Isolauri. 1997. Probiotics: A novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99: 179-185 https://doi.org/10.1016/S0091-6749(97)70093-9
  13. Pessi, T., Y. Sutas, M. Hurme, and E. Isolauri. 2000. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 30: 1804-1808 https://doi.org/10.1046/j.1365-2222.2000.00948.x
  14. Pohjavuori, E., M. Viljanen, R. Korpela, M. Kuitunen, M. Tiittanen, O. Vaarala, and E. Savilahti. 2004. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 114: 131-136 https://doi.org/10.1016/j.jaci.2004.03.036
  15. Queille, C., R. Pommarede, and J. H. Saurat. 1984. Efficacy versus systemic side effects of six topical steroids in the treatment of atopic dermatitis in childhood. Pediatr. Dermatol. 1: 246-253 https://doi.org/10.1111/j.1525-1470.1984.tb01124.x
  16. Raimer, S. S. 2000. Managing pediatric atopic dermatitis. Clin. Pediatr. 39: 1-14 https://doi.org/10.1177/000992280003900101
  17. Rajka, G. and T. Langeland. 1989. Grading of the severity of atopic dermatitis. Acta Derm. Venereol. Suppl. (Stockh.) 144: 13-14
  18. Rautava, S., M. Kalliomaki, and E. Isolauri. 2002. Probiotics during pregnancy and breast feeding might confer immunomodulatory protection against atopic disease in the infant. J. Allergy Clin. Immunol. 109: 119-121 https://doi.org/10.1067/mai.2002.120273
  19. Rosenfeldt, V., E. Benfeldt, S. D. Nielsen, K. F. Michaelsen, D. L. Jeppesen, N. H. Valerius, and A. Paerregaard. 2003. Effect of probiotic Lactobacillus strain in children with atopic dermatitis. J. Allergy Clin. Immunol. 11: 389-395
  20. Salminen, S., C. Bouley, M. C. Boutron-Ruault, J. H. Cummings, A. Franck, G. R. Gibson, E. Isolauri, M. C. Moreau, M. Roberfroid, and I. Rowland. 1998. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80: 147-171 https://doi.org/10.1079/BJN19980108
  21. Shyamasree, G., B. Suman, P. Santanu, D. Benubrata, K. B. Dilip, and M. Chitra. 2004. Increased interferon gamma production by peripheral blood mononuclear cells in response to stimulation of overexpressed disease-specific 9-O-acetylated sialoglycoconjugates in children suffering from acute lymphoblastic leukaemia. Br. J. Haematol. 128: 35-41 https://doi.org/10.1111/j.1365-2141.2004.05256.x
  22. Young, R. J. and S. Huffman. 2003. Probiotic use in children. J. Pediatr. Health Care 17: 277-283 https://doi.org/10.1016/S0891-5245(03)00070-1